JOHN B HENNEMAN III Insider Trading $NLNK LUMOS PHARMA, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN B HENNEMAN III.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK).

JOHN B HENNEMAN III in LUMOS PHARMA, INC.

Trading Symbol: NLNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B HENNEMAN III: EVP, Chief Financial Officer
Holdings: 47,789 shares
Current Value: $653,276
Latest Transaction: Jan 06 2015
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN B HENNEMAN III in LUMOS PHARMA, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 06 2015NLNKNEWLINK GENETICS C ...HENNEMAN JOHN B IIIEVP, Chief Financia ...Option ExerciseA43.656,500283,7256,500
Jan 06 2015NLNKNEWLINK GENETICS C ...HENNEMAN JOHN B IIIEVP, Chief Financia ...GrantA0.002,000047,78945.8 K to 47.8 K (+4.37 %)
Nov 25 2014NLNKNEWLINK GENETICS C ...HENNEMAN JOHN B IIIEVP, Chief Financia ...BuyP34.355,000171,75045,78940.8 K to 45.8 K (+12.26 %)
Oct 03 2014NLNKNEWLINK GENETICS C ...HENNEMAN JOHN B IIIEVP, Chief Financia ...Option ExerciseA22.95209,2504,802,288209,250
Oct 03 2014NLNKNEWLINK GENETICS C ...HENNEMAN JOHN B IIIEVP, Chief Financia ...GrantA0.0040,789040,7890 to 40.8 K

Page:   1